Newsletter Subject

FDA Allows Extra Doses of Bivalent COVID Vax for Immunocompromised Tots

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Apr 28, 2023 10:53 PM

Email Preheader Text

Daily Headlines Friday, April 28, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT T

[MEDPAGE TODAY]( Daily Headlines Friday, April 28, 2023 Today's Top Stories for {NAME} [INFECTIOUS DISEASE]( [FDA Allows Extra Doses of Bivalent COVID Vax for Immunocompromised Tots]( [SPECIAL REPORTS]( [DOJ Joins Challenge to Tennessee Transgender Youth Healthcare Ban]( [INFECTIOUS DISEASE]( [Patients Living With Long COVID Offer Insight to FDA]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Living with HR+/HER2- Breast Cancer: A Point-of-Care Oral Oncolytic Discussion Guide and Toolkit for Patients]( [PUBLIC HEALTH & POLICY]( [ACOG PAC Donated Over $1M to Anti-Abortion Legislators]( [OPINION]( [Mifepristone Battle Could Signal 'Pandora's Box' of Cases Against FDA Drugs]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [ONCOLOGY/HEMATOLOGY]( [Vit D and PD-1 Blockade; Low Implant-Related SCC Risk; Better Pay for Unused Meds]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Resistant and Refractory CMV Management]( [PULMONOLOGY]( [Cognitive Testing Flags COPD Patients Unable to Maintain Proper Inhaler Technique]( [INFECTIOUS DISEASE]( [More Efforts Needed to Combat Antimicrobial Resistance, Lawmakers Told]( [OPINION]( [How Every City Can Promote Health Equity for People With Autism]( CME SPOTLIGHT [Clinical Evidence for Current and Emerging Therapies in Relapsed/Refractory Multiple Myeloma]( [PEDIATRICS]( [ADHD Treatment: Many Kids May Be Falling Through the Cracks]( [SPECIAL REPORTS]( [My Health, My Data Act Signed Into Law in Washington State]( [ACR READING ROOM]( [Insights Into the Biology of Pain for Rheumatologists]( CME SPOTLIGHT [Guideline Recommendations for Treatment Selection and Sequencing in Relapsed/Refractory Multiple Myeloma]( [SURGERY]( [Sketchy Benefits With Corticosteroids Persist in Children's Heart Surgery]( [PULMONOLOGY]( [FDA Extends Trikafta Approval to Even Younger Cystic Fibrosis Patients]( [OPINION]( [Shameful Outcomes]( CME SPOTLIGHT [Expert Approaches to the Treatment and Management of Cytomegalovirus (CMV) in Transplant Recipients]( [ACR READING ROOM]( [Why Does Pain Sometimes Persist Even After Inflammation Is Controlled?]( [PRACTICE MANAGEMENT]( [ChatGPT Answers Beat Physicians' on Info, Patient Empathy, Study Finds]( CME SPOTLIGHT [Transforming Patient-Centered Care for HR+/HER2- Breast Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams]( # Weekly Survey [Can Amazon and Mark Cuban Lower U.S. Drug Costs?]( Pharmacies that largely bypass insurance -- including Amazon and Cost Plus Drugs -- are [offering cheap generics](, but they don't compete on branded drug pricing[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-04-28&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.